To assess their therapeutic potential, it is shown that LNPs made from ionizable lipids with helper lipids co‐encapsulating Cas9 mRNA and sgRNA targeting SOX2 (sgSOX2), lead to a ≈60% reduction in HNSCC cell viability in vitro. This evidence concerns the gene SOX2 and head and neck squamous cell carcinoma.